[Changes in indices of connective tissue in patients with alcoholic and non-alcoholic steatohepatitis and their correction with glutargin].
The study of protein and carbohydrate components of extracellular matrix in patients with alcoholic and non alcoholic steatohepatitis developed on the background of type 2 diabetes mellitus has shown a significant increase in collagen and glycosaminoglycan synthesis along with the enhancement of proteolytic and compensatory collagenous activity of blood plasma in patients with alcoholic steatohepatitis and inhibition of collagenolytic and proteolytic activity of blood plasma in patients with non alcoholic steatohepatitis against the background of diabetes mellitus, decrease in glycoprotein synthesis. Glutargin enhances metabolism of connective tissue by impeding collagen and glycosaminoglycan synthesis, activating proteoglycan production, augmenting blood plasma activity in patients with non alcoholic steatohepatitis, hindering proteolysis in patients with alcoholic steatohepatitis as well as increasing the excretion of connective tissue metabolites through urinary tracts.
Khukhlina
O S
OS
D000328:Adult; D003094:Collagen / Q000097:blood / Q000378:metabolism; D003238:Connective Tissue / Q000187:drug effects / Q000378:metabolism*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000378:metabolism; D004151:Dipeptides / Q000627:therapeutic use*; D005109:Extracellular Matrix / Q000187:drug effects / Q000378:metabolism; D005234:Fatty Liver / Q000150:complications / Q000188:drug therapy / Q000378:metabolism; D005235:Fatty Liver, Alcoholic / Q000150:complications / Q000188:drug therapy / Q000378:metabolism*; D006023:Glycoproteins / Q000097:blood / Q000378:metabolism; D006025:Glycosaminoglycans / Q000097:blood / Q000378:metabolism; D006801:Humans; D008875:Middle Aged; D020011:Protective Agents / Q000627:therapeutic use*
D004151:Dipeptides; D006023:Glycoproteins; D006025:Glycosaminoglycans; D020011:Protective Agents; D003094:Collagen; C024362:arginine glutamate